# Fluorescent Dyes for Lymph Node Mapping

> **NCT01095913** · PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 30 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Indocyanine green (ICG)

## Key facts

- **NCT ID:** NCT01095913
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2015-01-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01095913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01095913, "Fluorescent Dyes for Lymph Node Mapping". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01095913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*